Showing results (1481-1490 of 1,497) with videos related to
Sort By:
Pageof 150
Journal of Medicinal Chemistry|December 29, 2015
Discovery of Vibegron: A Potent and Selective β3 Adrenergic Receptor Agonist for the Treatment of Overactive BladderScott D Edmondson, Cheng Zhu, Nam Fung Kar, et al.Bioorganic & Medicinal Chemistry Letters|April 7, 2019
Accelerating the discovery of DGAT1 inhibitors through the application of parallel medicinal chemistry (PMC)Yang Yu, Zhicai Wu, Zhi-Cai Shi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 18, 2020
Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA TrialCristina Saura, Mafalda Oliveira, Yin-Hsun Feng, et al.ACS Medicinal Chemistry Letters|June 6, 2014
Potent DGAT1 Inhibitors in the Benzimidazole Class with a Pyridyl-oxy-cyclohexanecarboxylic Acid MoietyShuwen He, Qingmei Hong, Zhong Lai, et al.Nature Communications|August 11, 2018
Identification of recurrent USP48 and BRAF mutations in Cushing's diseaseJianhua Chen, Xuemin Jian, Siyu Deng, et al.Bioorganic & Medicinal Chemistry Letters|March 31, 2019
Benzimidazole-based DGAT1 inhibitors with a [3.1.0] bicyclohexane carboxylic acid moietyShuwen He, Zhong Lai, Qingmei Hong, et al.Cancer Letters|July 12, 2025
Deglycosylated PD-L1 is a biomarker for immune checkpoint blockade response: a real-world study in breast cancer patients in TaiwanShao-Chun Wang, Yi-Chun Shen, Mei-Ren Pan, et al.ACS Medicinal Chemistry Letters|October 29, 2014
Discovery of a Potent and Selective DGAT1 Inhibitor with a Piperidinyl-oxy-cyclohexanecarboxylic Acid MoietyShuwen He, Qingmei Hong, Zhong Lai, et al.Journal of Digestive Diseases|April 8, 2025
Chinese Guideline for the Diagnosis and Management of Drug-Induced Liver Injury in Primary Care (2024)Yi Min Mao, Jie Ting Tang, Zhong Hua Lu, et al.Nature Genetics|June 2, 2015
Common variants at 10p12.31, 10q21.1 and 13q12.13 are associated with sporadic pituitary adenomaZhao Ye, Zhiqiang Li, Yongfei Wang, et al.Pageof 150